Biocure Technology Inc (CURE.CX)
0.015
0.00 (0.00%)
CAD |
CNSX |
May 16, 16:00
Biocure Technology Net Income (Quarterly): -4.008M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.008M |
| September 30, 2023 | -0.1132M |
| June 30, 2023 | 2.621M |
| March 31, 2023 | -0.3132M |
| December 31, 2022 | -0.577M |
| September 30, 2022 | -0.2881M |
| June 30, 2022 | -0.2768M |
| March 31, 2022 | -0.3082M |
| December 31, 2021 | 3.201M |
| September 30, 2021 | -1.385M |
| June 30, 2021 | -1.558M |
| March 31, 2021 | -1.386M |
| December 31, 2020 | -1.428M |
| September 30, 2020 | -0.4219M |
| June 30, 2020 | -0.4776M |
| March 31, 2020 | -0.6186M |
| December 31, 2019 | -1.576M |
| September 30, 2019 | -0.7276M |
| June 30, 2019 | -1.869M |
| March 31, 2019 | -0.5673M |
| December 31, 2018 | -1.221M |
| September 30, 2018 | -0.5061M |
| June 30, 2018 | -3.849M |
| March 31, 2018 | -1.01M |
| December 31, 2017 | -3.196M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.4593M |
| June 30, 2017 | -0.0217M |
| September 30, 2016 | -0.0388M |
| June 30, 2016 | -0.0143M |
| March 31, 2016 | -0.005M |
| December 31, 2015 | -0.0338M |
| September 30, 2015 | -0.0156M |
| June 30, 2015 | -0.0158M |
| March 31, 2015 | -0.0216M |
| December 31, 2014 | -0.0164M |
| September 30, 2014 | -0.0241M |
| June 30, 2014 | -0.0215M |
| March 31, 2014 | 0.0953M |
| December 31, 2013 | -0.014M |
| September 30, 2013 | -0.0253M |
| June 30, 2013 | -0.0192M |
| March 31, 2013 | 0.0485M |
| December 31, 2012 | -0.0238M |
| September 30, 2012 | -0.0168M |
| June 30, 2012 | -0.0393M |
| March 31, 2012 | -0.0224M |
| December 31, 2011 | -0.0281M |
| September 30, 2011 | -0.0133M |
| June 30, 2011 | -0.0432M |
| March 31, 2011 | 0.0766M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-4.008M
Minimum
Dec 2023
3.201M
Maximum
Dec 2021
-0.6058M
Average
-0.577M
Median
Dec 2022
Net Income (Quarterly) Benchmarks
| Core One Labs Inc | -0.8407M |
| Nova Mentis Life Science Corp | -0.1841M |
| Nanosphere Health Sciences Inc | -0.0748M |
| Lobe Sciences Ltd | -0.5955M |
| Algernon Pharmaceuticals Inc | -1.88M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.8408M |
| EPS Diluted (Quarterly) | -0.04 |
| Enterprise Value | 1.448M |
| Earnings Yield | -95.08% |
| Normalized Earnings Yield | -395.92 |